うっ血性心不全治療デバイスの世界市場レポート 2025年

うっ血性心不全治療デバイス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.8％で286億4,000万米ドルに成長します。予測期間の成長は、高齢化人口の増加、心臓の健康に対する意識の高まり、検診プログラムの実施、構造的心臓処置に対する有利な償還政策、新しい構造的心臓デバイスのタイムリーな規制承認などに起因しています。予測期間における主な動向としては、経カテーテル弁置換術の採用増加、先進素材を用いた革新的デバイスの開発継続、個別化治療アプローチの重視の高まり、ハイブリッド手技の採用増加、遠隔モニタリングおよび遠隔医療ソリューションの統合などが挙げられます。

心血管障害の有病率の増加は、今後数年間におけるうっ血性心不全（CHF）治療機器市場の成長を促進すると予想されます。心血管疾患には、冠動脈疾患、高血圧、心不全など、心臓や血管に影響を及ぼす幅広い疾患が含まれ、いずれも血液循環や心臓全体の健康に影響を及ぼします。このような心血管疾患の増加は、肥満、座りがちなライフスタイル、食生活の乱れ、高齢化といった危険因子の増加が主な原因です。うっ血性心不全治療デバイスは、心臓のリズムを調整し、心臓の機能を改善することによって、これらの疾患を管理する上で重要な役割を果たし、それによって患者の予後を著しく向上させる。例えば、英国を拠点とする慈善団体Charity Todayの2024年1月の報告書によると、英国では2022年に3万9,000人以上が心臓発作、冠動脈性心疾患、脳卒中などの心血管疾患で早死にしています。その結果、心血管疾患の有病率の増加がCHF治療機器市場の成長を促進しています。

うっ血性心不全治療デバイス市場の主要企業は、心拍同期の改善、従来のペースメーカーリードに伴うリスクの最小化、患者の快適性の向上、心不全症状のより効果的な管理を実現するために、デュアルチャンバー型リードレスペースメーカーなどの革新的な製品の開発に注力しています。これらの進歩は、患者のQOLを改善し、不整脈患者の再入院を減らすことを目的としています。デュアルチャンバー型リードレスペースメーカーは、通常心臓に埋め込む従来のリード（ワイヤー）を必要とせずに心臓のリズムを調整するように設計された最先端のデバイスです。例えば、2022年2月、米国のヘルスケア企業であるアボット・ラボラトリーズは、極めて重要な臨床試験において、世界初の両室リードレスペースメーカーの植え込みに成功しました。この画期的なデバイスは、従来のリード線なしで心臓のリズム管理を可能にし、侵襲の少ない処置を提供します。デュアルチャンバーデザインは、心房と心室の両方に同時にペーシングを行うことを容易にし、心臓疾患の管理を改善します。この技術革新は、患者により便利で効果的な心臓リズム障害の解決策を提供し、病院への通院を減らし、全体的な生活の質を向上させることを目的としています。この装置の性能は高度な技術によって継続的にモニターされ、心臓の健康を継続的に監視することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界うっ血性心不全治療デバイス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のうっ血性心不全治療デバイス市場：成長率分析
• 世界のうっ血性心不全治療デバイス市場の実績：規模と成長, 2019-2024
• 世界のうっ血性心不全治療デバイス市場の予測：規模と成長, 2024-2029, 2034F
• 世界うっ血性心不全治療デバイス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のうっ血性心不全治療デバイス市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓ペースメーカー
• 植込み型除細動器（ICD）
• 心臓再同期療法装置（CRT）
• カウンターパルセーション装置
• 心室補助装置（VAD）
• 世界のうっ血性心不全治療デバイス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 左室補助装置（LVAD）
• 右室補助装置（RVAD）
• 両室補助装置（BIVAD）
• 世界のうっ血性心不全治療デバイス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院とクリニック
• 専門心血管疾患治療センター
• 外来手術センター
• 世界のうっ血性心不全治療デバイス市場心臓ペースメーカーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単腔ペースメーカー
• デュアルチャンバーペースメーカー
• 両室ペースメーカー
• 世界のうっ血性心不全治療デバイス市場植込み型除細動器（ICD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来のICD
• 皮下ICD
• CRT-D（心臓再同期療法除細動器）
• 世界のうっ血性心不全治療デバイス市場心臓再同期療法装置（CRT）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRT-P（心臓再同期療法ペースメーカー）
• CRT-D（心臓再同期療法除細動器）
• 世界のうっ血性心不全治療デバイス市場、カウンターパルセーション装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大動脈内バルーンポンプ（IABP）
• 外部カウンターパルセーション装置（ECP）
• 世界のうっ血性心不全治療デバイス市場心室補助装置（VAD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 左室補助装置（LVAD）
• 右室補助装置（RVAD）
• 両室補助装置（BiVAD）

第7章 地域別・国別分析

• 世界のうっ血性心不全治療デバイス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のうっ血性心不全治療デバイス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• うっ血性心不全治療デバイス市場：競合情勢
• うっ血性心不全治療デバイス市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Edwards Lifesciences Corporation
• Charles River Laboratories International Inc.
• W. L. Gore & Associates Inc.
• Bracco Group
• LivaNova PLC
• Meril Life Sciences Pvt. Ltd.
• Biotronik SE & Co. KG
• CryoLife Inc.
• HeartWare International Inc.
• Direct Flow Medical Inc.
• Berlin Heart GmbH
• CVRx Inc.
• Micro Interventional Devices Inc.
• Jarvik Heart Inc.
• CardioKinetix Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• うっ血性心不全治療デバイス市場2029：新たな機会を提供する国
• うっ血性心不全治療デバイス市場2029：新たな機会を提供するセグメント
• うっ血性心不全治療デバイス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A congestive heart failure (CHF) treatment device is a medical tool created to assist in managing and addressing the effects of this condition, wherein the heart struggles to efficiently pump blood, resulting in fluid accumulation in the lungs and other tissues. Such devices play a role in monitoring, supporting, or enhancing heart function, thereby mitigating symptoms and reducing the likelihood of complications and hospitalizations associated with congestive heart failure.

The primary types of devices used in treating congestive heart failure encompass cardiac pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, counter-pulsation devices, and ventricular assist devices (VADs). A cardiac pacemaker, for example, is a small implant placed in the chest to regulate irregular heart rhythms by delivering electrical impulses to restore a normal heartbeat. These devices, including left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs), find utility across various settings, including hospitals, specialized cardiovascular treatment centers, and ambulatory surgery centers.

The congestive heart failure treatment devices market research report is one of a series of new reports from The Business Research Company that provides congestive heart failure treatment devices market statistics, including congestive heart failure treatment devices industry global market size, regional shares, competitors with a congestive heart failure treatment devices market share, detailed congestive heart failure treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the congestive heart failure treatment devices industry. This congestive heart failure treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congestive heart failure treatment devices market size has grown strongly in recent years. It will grow from $19.61 billion in 2024 to $21.21 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for minimally invasive structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, and growing patient preference for non-surgical or minimally invasive treatment options.

The congestive heart failure treatment devices market size is expected to see strong growth in the next few years. It will grow to $28.64 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, and timely regulatory approvals for new structural heart devices. Major trends in the forecast period include increasing adoption of transcatheter valve replacement, ongoing development of innovative devices with advanced materials, growing emphasis on personalized treatment approaches, increasing adoption of hybrid procedures, and integration of remote monitoring and telehealth solutions.

The increasing prevalence of cardiovascular disorders is expected to drive the growth of the congestive heart failure (CHF) treatment devices market in the coming years. Cardiovascular disorders include a wide range of diseases that affect the heart and blood vessels, such as coronary artery disease, hypertension, and heart failure, all of which impact blood circulation and overall heart health. This rise in cardiovascular conditions is largely attributed to growing risk factors like obesity, sedentary lifestyles, poor dietary habits, and aging populations. Congestive heart failure treatment devices play a vital role in managing these disorders by regulating heart rhythms and improving heart function, thereby significantly enhancing patient outcomes. For example, a report by Charity Today, a UK-based charitable organization, stated in January 2024 that over 39,000 people in England died prematurely from cardiovascular conditions, including heart attacks, coronary heart disease, and stroke, in 2022. As a result, the increasing prevalence of cardiovascular diseases is fueling the growth of the CHF treatment devices market.

Leading companies in the congestive heart failure treatment devices market are focusing on developing innovative products, such as dual-chamber leadless pacemakers, to improve heart rhythm synchronization, minimize the risks associated with traditional pacemaker leads, enhance patient comfort, and provide more effective management of heart failure symptoms. These advancements aim to improve patients' quality of life and reduce hospital readmissions for those with arrhythmias. A dual-chamber leadless pacemaker is a cutting-edge device designed to regulate heart rhythms without the need for traditional leads (wires) typically implanted in the heart. For example, in February 2022, Abbott Laboratories, a US-based healthcare company, successfully implanted the world's first dual-chamber leadless pacemaker during a pivotal clinical trial. This groundbreaking device allows for heart rhythm management without the need for conventional leads, offering a less invasive procedure. The dual-chamber design facilitates simultaneous pacing of both the atrium and ventricle, improving the management of heart conditions. This innovation aims to provide patients with a more convenient and effective solution for heart rhythm disorders, potentially reducing hospital visits and enhancing overall quality of life. The device's performance is continuously monitored through advanced technologies, ensuring ongoing oversight of cardiac health.

In December 2022, Johnson & Johnson Services Inc., a pharmaceutical and medical technology company based in the United States, completed the acquisition of Abiomed Inc. for $16.6 billion. Through this strategic move, Johnson & Johnson aims to broaden its presence in the rapidly expanding cardiovascular device market, especially in the segments related to heart failure and recovery solutions. Abiomed Inc., headquartered in the United States, specializes in manufacturing devices for the treatment of congestive heart failure.

Major companies operating in the congestive heart failure treatment devices market are Abbott Laboratories, Medtronic plc, Baxter International Inc., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Charles River Laboratories International Inc., W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Biotronik SE & Co. KG, CryoLife Inc., HeartWare International Inc., Direct Flow Medical Inc., Berlin Heart GmbH, CVRx Inc., Micro Interventional Devices Inc., Jarvik Heart Inc, CardioKinetix Inc, Xeltis AG, Ancora Heart Inc, ReliantHeart Inc.

North America was the largest region in the congestive heart failure treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the congestive heart failure treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The congestive heart failure treatment device market consists of sales of external defibrillators, total artificial hearts (TAHs), implantable cardioverter defibrillators, and intra-aortic balloon pumps (IABPs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congestive Heart Failure Treatment Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congestive heart failure treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congestive heart failure treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The congestive heart failure treatment devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Cardiac Pacemaker; Implantable Cardioverter Defibrillators (ICDs); Cardiac Resynchronization Therapy Devices (CRT); Counter Pulsation Devices; Ventricular Assist Devices (VADs)
• 2) By Application: Left Ventricular Assist Device (LVAD); Right Ventricular Assist Device (RVAD); Biventricular Assist Device (BIVAD)
• 3) By End-User: Hospitals And Clinic; Specialized Cardiovascular Disease Treatment Centers; Ambulatory Surgery Centers
• Subsegments:
• 1) By Cardiac Pacemaker: Single Chamber Pacemaker; Dual Chamber Pacemaker; Biventricular Pacemaker
• 2) By Implantable Cardioverter Defibrillators (ICDs): Traditional ICDs; Subcutaneous ICDs; CRT-D (Cardiac Resynchronization Therapy Defibrillator)
• 3) By Cardiac Resynchronization Therapy Devices (CRT): CRT-P (Cardiac Resynchronization Therapy Pacemaker); CRT-D (Cardiac Resynchronization Therapy Defibrillator)
• 4) By Counter Pulsation Devices: Intra-Aortic Balloon Pumps (IABP); External Counterpulsation Devices (ECP)
• 5) By Ventricular Assist Devices (VADs): Left Ventricular Assist Devices (LVAD); Right Ventricular Assist Devices (RVAD); Biventricular Assist Devices (BiVAD)
• Companies Mentioned: Abbott Laboratories; Medtronic plc; Baxter International Inc.; Boston Scientific Corporation; Terumo Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Congestive Heart Failure Treatment Devices Market Characteristics

3. Congestive Heart Failure Treatment Devices Market Trends And Strategies

4. Congestive Heart Failure Treatment Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Congestive Heart Failure Treatment Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Congestive Heart Failure Treatment Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Congestive Heart Failure Treatment Devices Market Growth Rate Analysis
• 5.4. Global Congestive Heart Failure Treatment Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Congestive Heart Failure Treatment Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Congestive Heart Failure Treatment Devices Total Addressable Market (TAM)

6. Congestive Heart Failure Treatment Devices Market Segmentation

• 6.1. Global Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Pacemaker
• Implantable Cardioverter Defibrillators (ICDs)
• Cardiac Resynchronization Therapy Devices (CRT)
• Counter Pulsation Devices
• Ventricular Assist Devices (VADs)
• 6.2. Global Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Left Ventricular Assist Device (LVAD)
• Right Ventricular Assist Device (RVAD)
• Biventricular Assist Device (BIVAD)
• 6.3. Global Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinic
• Specialized Cardiovascular Disease Treatment Centers
• Ambulatory Surgery Centers
• 6.4. Global Congestive Heart Failure Treatment Devices Market, Sub-Segmentation Of Cardiac Pacemaker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Chamber Pacemaker
• Dual Chamber Pacemaker
• Biventricular Pacemaker
• 6.5. Global Congestive Heart Failure Treatment Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillators (ICDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional ICDs
• Subcutaneous ICDs
• CRT-D (Cardiac Resynchronization Therapy Defibrillator)
• 6.6. Global Congestive Heart Failure Treatment Devices Market, Sub-Segmentation Of Cardiac Resynchronization Therapy Devices (CRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRT-P (Cardiac Resynchronization Therapy Pacemaker)
• CRT-D (Cardiac Resynchronization Therapy Defibrillator)
• 6.7. Global Congestive Heart Failure Treatment Devices Market, Sub-Segmentation Of Counter Pulsation Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intra-Aortic Balloon Pumps (IABP)
• External Counterpulsation Devices (ECP)
• 6.8. Global Congestive Heart Failure Treatment Devices Market, Sub-Segmentation Of Ventricular Assist Devices (VADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Left Ventricular Assist Devices (LVAD)
• Right Ventricular Assist Devices (RVAD)
• Biventricular Assist Devices (BiVAD)

7. Congestive Heart Failure Treatment Devices Market Regional And Country Analysis

• 7.1. Global Congestive Heart Failure Treatment Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Congestive Heart Failure Treatment Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congestive Heart Failure Treatment Devices Market

• 8.1. Asia-Pacific Congestive Heart Failure Treatment Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congestive Heart Failure Treatment Devices Market

• 9.1. China Congestive Heart Failure Treatment Devices Market Overview
• 9.2. China Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congestive Heart Failure Treatment Devices Market

• 10.1. India Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congestive Heart Failure Treatment Devices Market

• 11.1. Japan Congestive Heart Failure Treatment Devices Market Overview
• 11.2. Japan Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congestive Heart Failure Treatment Devices Market

• 12.1. Australia Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congestive Heart Failure Treatment Devices Market

• 13.1. Indonesia Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congestive Heart Failure Treatment Devices Market

• 14.1. South Korea Congestive Heart Failure Treatment Devices Market Overview
• 14.2. South Korea Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congestive Heart Failure Treatment Devices Market

• 15.1. Western Europe Congestive Heart Failure Treatment Devices Market Overview
• 15.2. Western Europe Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congestive Heart Failure Treatment Devices Market

• 16.1. UK Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congestive Heart Failure Treatment Devices Market

• 17.1. Germany Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congestive Heart Failure Treatment Devices Market

• 18.1. France Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congestive Heart Failure Treatment Devices Market

• 19.1. Italy Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congestive Heart Failure Treatment Devices Market

• 20.1. Spain Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congestive Heart Failure Treatment Devices Market

• 21.1. Eastern Europe Congestive Heart Failure Treatment Devices Market Overview
• 21.2. Eastern Europe Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congestive Heart Failure Treatment Devices Market

• 22.1. Russia Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congestive Heart Failure Treatment Devices Market

• 23.1. North America Congestive Heart Failure Treatment Devices Market Overview
• 23.2. North America Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congestive Heart Failure Treatment Devices Market

• 24.1. USA Congestive Heart Failure Treatment Devices Market Overview
• 24.2. USA Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congestive Heart Failure Treatment Devices Market

• 25.1. Canada Congestive Heart Failure Treatment Devices Market Overview
• 25.2. Canada Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congestive Heart Failure Treatment Devices Market

• 26.1. South America Congestive Heart Failure Treatment Devices Market Overview
• 26.2. South America Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congestive Heart Failure Treatment Devices Market

• 27.1. Brazil Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congestive Heart Failure Treatment Devices Market

• 28.1. Middle East Congestive Heart Failure Treatment Devices Market Overview
• 28.2. Middle East Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congestive Heart Failure Treatment Devices Market

• 29.1. Africa Congestive Heart Failure Treatment Devices Market Overview
• 29.2. Africa Congestive Heart Failure Treatment Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Congestive Heart Failure Treatment Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Congestive Heart Failure Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congestive Heart Failure Treatment Devices Market Competitive Landscape And Company Profiles

• 30.1. Congestive Heart Failure Treatment Devices Market Competitive Landscape
• 30.2. Congestive Heart Failure Treatment Devices Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Congestive Heart Failure Treatment Devices Market Other Major And Innovative Companies

• 31.1. Edwards Lifesciences Corporation
• 31.2. Charles River Laboratories International Inc.
• 31.3. W. L. Gore & Associates Inc.
• 31.4. Bracco Group
• 31.5. LivaNova PLC
• 31.6. Meril Life Sciences Pvt. Ltd.
• 31.7. Biotronik SE & Co. KG
• 31.8. CryoLife Inc.
• 31.9. HeartWare International Inc.
• 31.10. Direct Flow Medical Inc.
• 31.11. Berlin Heart GmbH
• 31.12. CVRx Inc.
• 31.13. Micro Interventional Devices Inc.
• 31.14. Jarvik Heart Inc.
• 31.15. CardioKinetix Inc.

32. Global Congestive Heart Failure Treatment Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congestive Heart Failure Treatment Devices Market

34. Recent Developments In The Congestive Heart Failure Treatment Devices Market

35. Congestive Heart Failure Treatment Devices Market High Potential Countries, Segments and Strategies

• 35.1 Congestive Heart Failure Treatment Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Congestive Heart Failure Treatment Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Congestive Heart Failure Treatment Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer